MERRIMACK PHARMACEUTICALS INC Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-02-13: Reporting owner Mulroy Robert J.; Form 5; Security Series D Convertible Preferred Stock; Transaction Holding.
- 2013-02-13: Reporting owner Mulroy Robert J.; Form 5; Security Series G Convertible Preferred Stock; Transaction Holding.
- 2012-04-03: Reporting owner Mulroy Robert J.; Form 5; Security Series D Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2012-04-03: Reporting owner Mulroy Robert J.; Form 5; Security Series G Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-02-13 holding as of filing | Mulroy Robert J. Director, Officer (President and CEO) | 5 | Series D Convertible Preferred Stock Derivative · Indirect · By Trust | Holding | 199,993 owned after | no price filed | 2013-02-13 | |
| 2013-02-13 holding as of filing | Mulroy Robert J. Director, Officer (President and CEO) | 5 | Series G Convertible Preferred Stock Derivative · Indirect · By Trust | Holding | 17,142 owned after | no price filed | 2013-02-13 |